Last Updated: 31-07-2025 | Format: PDF | Report ID:20346 | Author: Alice
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,010 Million |
| What is the projected market size by 2035? | $2,950 Million |
| What is the market CAGR from 2025 to 2035? | 11.3% |
| Which region dominates the market? | US (73%) |
| Which product/service type dominates the market? | Comprehensive Panel (32%) |
| Which application leads the market? | Cancer Risk Assessment (36%) |
| Who are the major buyers? | Hospitals (35%), Diagnostic Laboratories (27%) |
| What are the key market growth drivers? | Advancements in next-generation sequencing technology drive faster and more cost-effective gene panel development; Increasing adoption of gene panels for cancer risk assessment |
| What are the major market challenges? | Ensuring data privacy and security as patient genome data proliferates; BGI Genomics is investing in advanced encryption and compliance post-2024 regulatory scrutiny; Integration gaps in existing healthcare IT systems hinder seamless adoption; Eurofins Scientific is piloting interoperability solutions to bridge these divides across clinical networks |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| What is the forecast period? |
| 2026–2035 |
| Who are the key market players? | Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Roche, BGI Genomics, Eurofins Scientific, Foundation Medicine, GENEWIZ, Myriad Genetics, PerkinElmer, Invitae, ArcherDX, CENTOGENE, Fulgent Genetics |
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Transfection Reagents and Equipment Market: by Type (Reagents, Instruments), Application (Biomedical Research, Therapeutic Delivery, Protein Production, Cancer Research, Gene Therapy, Others), Distribution Channels (Direct Tenders, Retail Sales, E-commerce, Distributors, Wholesalers, Others), Technology (Physical, Chemical, Biological, Viral-mediated, Electroporation, Lipofection), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America mRNA Synthesis & Manufacturing Market: by Type (Synthetic mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA, Circular mRNA, Purified mRNA), Application (Vaccines, Cancer Immunotherapy, Protein Replacement Therapy, Gene Editing, Research Applications, Rare Diseases), Distribution Channels (Direct Sales, Distributors, Online Platforms, Retail Pharmacies, Hospital Pharmacies, Others), Technology (In vitro Transcription, Enzymatic Synthesis, Lipid Nanoparticle Formulation, Purification Technologies, Polymerase Chain Reaction, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Gene Expression Analysis Market: by Type (Consumables, Instruments, Software, Services), Application (Drug Discovery, Diagnostics, Research, Personalized Medicine, Agriculture, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Others), Technology (PCR, Microarray, NGS, Sanger Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025